21 U.S. Code § 356e - Drug shortage list
Subject to paragraphs (2) and (3), the Secretary shall make the information in such list publicly available.
The Secretary may choose not to make information collected under this section publicly available under paragraph (1) or section 356c(c) of this title if the Secretary determines that disclosure of such information would adversely affect the public health (such as by increasing the possibility of hoarding or other disruption of the availability of drug products to patients).
2016—Subsec. (b)(3)(E). Pub. L. 114–255, which directed substitution of “discontinuance” for “discontinuation”, was executed by substituting “Discontinuance” for “Discontinuation” to reflect the probable intent of Congress.
LII has no control over and does not endorse any external Internet site that contains links to or references LII.